Is modulation of immune checkpoints on glioblastoma-infiltrating myeloid cells a viable therapeutic strategy? - Du R; Zhang J; Lukas RV; Tripathi S; Ahrendsen JT; Curran MA; Dmello C; Zhang P; Stupp R; Rao G; Heimberger AB (Neuro-oncology, 2025)